Literature DB >> 10529234

Both ATP sites of human P-glycoprotein are essential but not symmetric.

C A Hrycyna1, M Ramachandra, U A Germann, P W Cheng, I Pastan, M M Gottesman.   

Abstract

Human P-glycoprotein (P-gp) is a cell surface drug efflux pump that contains two nucleotide binding domains (NBDs). Mutations were made in each of the Walker B consensus motifs of the NBDs at positions D555N and D1200N, thought to be involved in Mg(2+) binding. Although the mutant and wild-type P-gps were expressed equivalently at the cell surface and bound the drug analogue [(125)I]iodoarylazidoprazosin ([(125)I]IAAP) comparably, neither of the mutant proteins was able to transport fluorescent substrates nor had detectable basal nor drug-stimulated ATPase activities. The wild-type and D1200N P-gps were labeled comparably with [alpha-(32)P]-8-azido-ATP at a subsaturating concentration of 2.5 microM, whereas labeling of the D555N mutant was severely impaired. Mild trypsin digestion, to cleave the protein into two halves, demonstrated that the N-half of the wild-type and D1200N proteins was labeled preferentially with [alpha-(32)P]-8-azido-ATP. [alpha-(32)P]-8-Azido-ATP labeling at 4 degrees C was inhibited in a concentration-dependent manner by ATP with half-maximal inhibition at approximately 10-20 microM for the P-gp-D1200N mutant and wild-type P-gp. A chimeric protein containing two N-half NBDs was found to be functional for transport and was also asymmetric with respect to [alpha-(32)P]-8-azido-ATP labeling, suggesting that the context of the ATP site rather than its exact sequence is an important determinant for ATP binding. By use of [alpha-(32)P]-8-azido-ATP and vanadate trapping, it was determined that the C-half of wild-type P-gp was labeled preferentially under hydrolysis conditions; however, the N-half was still capable of being labeled with [alpha-(32)P]-8-azido-ATP. Neither mutant was labeled under vanadate trapping conditions, indicating loss of ATP hydrolysis activity in the mutants. In confirmation of the lack of ATP hydrolysis, no inhibition of [(125)I]IAAP labeling was observed in the mutants in the presence of vanadate. Taken together, these data suggest that the two NBDs are asymmetric and intimately linked and that a conformational change in the protein may occur upon ATP hydrolysis. Furthermore, these data are consistent with a model in which binding of ATP to one site affects ATP hydrolysis at the second site.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10529234     DOI: 10.1021/bi991115m

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  33 in total

Review 1.  Structure and function of efflux pumps that confer resistance to drugs.

Authors:  M Ines Borges-Walmsley; Kenneth S McKeegan; Adrian R Walmsley
Journal:  Biochem J       Date:  2003-12-01       Impact factor: 3.857

Review 2.  ABC transporters and their role in nucleoside and nucleotide drug resistance.

Authors:  Yu Fukuda; John D Schuetz
Journal:  Biochem Pharmacol       Date:  2012-01-20       Impact factor: 5.858

3.  The hydroxyl group of S685 in Walker A motif and the carboxyl group of D792 in Walker B motif of NBD1 play a crucial role for multidrug resistance protein folding and function.

Authors:  Runying Yang; Robert Scavetta; Xiu-Bao Chang
Journal:  Biochim Biophys Acta       Date:  2007-11-29

Review 4.  The mechanism of action of multidrug-resistance-linked P-glycoprotein.

Authors:  Z E Sauna; M M Smith; M Müller; K M Kerr; S V Ambudkar
Journal:  J Bioenerg Biomembr       Date:  2001-12       Impact factor: 2.945

5.  Strict coupling between CFTR's catalytic cycle and gating of its Cl- ion pore revealed by distributions of open channel burst durations.

Authors:  László Csanády; Paola Vergani; David C Gadsby
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-04       Impact factor: 11.205

6.  Conserved Asp327 of walker B motif in the N-terminal nucleotide binding domain (NBD-1) of Cdr1p of Candida albicans has acquired a new role in ATP hydrolysis.

Authors:  Versha Rai; Manisha Gaur; Sudhanshu Shukla; Suneet Shukla; Suresh V Ambudkar; Sneha Sudha Komath; Rajendra Prasad
Journal:  Biochemistry       Date:  2006-12-12       Impact factor: 3.162

7.  Insights Into the Molecular Mechanism of Triptan Transport by P-glycoprotein.

Authors:  Laura A Wilt; Diana Nguyen; Arthur G Roberts
Journal:  J Pharm Sci       Date:  2017-03-07       Impact factor: 3.534

8.  The ATPase activity of the P-glycoprotein drug pump is highly activated when the N-terminal and central regions of the nucleotide-binding domains are linked closely together.

Authors:  Tip W Loo; M Claire Bartlett; Michael R Detty; David M Clarke
Journal:  J Biol Chem       Date:  2012-06-14       Impact factor: 5.157

Review 9.  A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function.

Authors:  King Leung Fung; Michael M Gottesman
Journal:  Biochim Biophys Acta       Date:  2009-03-11

10.  Molecular models of human P-glycoprotein in two different catalytic states.

Authors:  Jean-Paul Becker; Grégoire Depret; Françoise Van Bambeke; Paul M Tulkens; Martine Prévost
Journal:  BMC Struct Biol       Date:  2009-01-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.